Key points are not available for this paper at this time.
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of anti‐angiogenesis agents for the treatment of metastatic and recurrent cervical cancer.
Rizzuto et al. (Fri,) studied this question.